Skip to content
value.today

Apollo Endosurgery Inc.

Total raised
$112 M
3 rounds on record
Latest round
$54 M
Dec 2016
First round on record
Oct 2011
Today
Private
No later event on record

Funding rounds

3 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Apollo Endosurgery Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2016$54 MNo. 3$50 to $250 million

Apollo Endosurgery Inc.: Raise no. 3, Dec 2016

Investors in this round

15 investors had bought by the notice of Jan 11, 2017: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$54 M of $54 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Common Stock
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Bret Schwartzhoff · Executive Officer
  • Charles Tribie · Executive Officer
  • Dennis McWilliams · Executive Officer
  • Stefanie Cavanaugh · Executive Officer
  • Todd Newton · Executive Officer, Director
  • Bruce Robertson, Ph.D. · Director
  • Jack Nielsen · Director
  • John Creecy · Director
  • Matthew Crawford · Director
  • R. Kent McGaughy, Jr. · Director
  • Richard Meelia · Director
  • Rick Anderson · Director
  • William McClellan, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general corporate purposes including, but not limited to, executive salaries.”

Signed by Todd Newton, Ceo. Source: SEC Form D, newest notice filed Jan 11, 2017. Read the notice at the SEC.

equitySEC
Dec 2013$61 MIssued in a merger or acquisition$50 to $250 million

Apollo Endosurgery Inc.: Private sale, Dec 2013

Investors in this round

11 investors had bought by the notice of Dec 16, 2013: 11 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$61 M of $64 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: (1) Series C Preferred Stock; Common Stock issuable upon conversion and (2) Warrant for Series C Preferred Stock; Series C Preferred Stock issuable upon exercise; Common Stock issuable upon conversion
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis L McWilliams · Executive Officer, Director
  • Michael J Doty · Executive Officer
  • Bruce S Robertson · Director
  • Jack B Nielsen · Director
  • John W Creecy · Director
  • Matthew S Crawford · Director
  • R. Kent B McGaughy, Jr. · Director
  • Richard J Meelia · Director
  • Rick J Anderson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The Total Offering Amount and Total Amount Sold above both include amounts which will be received if the warrant is fully exercised.”
  • On a merger: “The consideration for the shares purchased by one investor was paid by the transfer of assets and liabilities pursuant to the terms of a master purchase agreement between such investor and the Issuer.”

Signed by Dennis L. McWilliams, President. Source: SEC Form D, newest notice filed Dec 16, 2013. Read the notice at the SEC.

equity, optionsSEC
Jun 2013$5 MNo. 2$2 to $10 million

Apollo Endosurgery Inc.: Raise no. 2, Jun 2013

Investors in this round

8 investors had bought by the notice of Jul 3, 2013: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $12 M offered; $7 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them, other: (i) convertible promissory notes; preferred stock upon conversion; common stock upon conversion and (ii) warrant to purchase common stock; common stock upon exercise
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis McWilliams · Executive Officer, Director
  • Michael S. Doty · Executive Officer
  • Bruce S. Robertson · Director
  • Jack S. Nielsen · Director
  • John S. Creecy · Director
  • Matthew S. Crawford · Director
  • R. Kent S. McGaughy, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Dennis McWilliams, President. Source: SEC Form D, newest notice filed Jul 3, 2013. Read the notice at the SEC.

debt, optionsSEC
Oct 2011$53 MNo. 1$50 to $250 million

Apollo Endosurgery Inc.: Raise no. 1, Oct 2011

Investors in this round

14 investors had bought by the notice of Feb 10, 2012: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$53 M of $54 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Dennis McWilliams · Executive Officer, Director
  • Michael S. Doty · Executive Officer
  • Bruce S. Robertson · Director
  • Jack S. Nielsen · Director
  • John S. Creecy · Director
  • Matthew S. Crawford · Director
  • R. Kent S. McGaughy, Jr. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Proceeds will be used for general coporate purposes including, but not limited to, executive salaries.”

Signed by Dennis McWilliams, President. Source: SEC Form D, newest notice filed Feb 10, 2012. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Apollo Endosurgery Inc. chose not to state its revenue in its newest notice of a funding round (Jan 2017).

    SEC Form D · Jan 2017

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2017

That is all the official record says: Apollo Endosurgery Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Apollo Endosurgery Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Apollo Endosurgery Inc.
NameRoleNamed in
Bret SchwartzhoffExecutive officerJan 2017
Charles TribieExecutive officerJan 2017
Dennis McWilliamsExecutive officerJan 2017
Stefanie CavanaughExecutive officerJan 2017
Todd NewtonExecutive officerJan 2017
Dennis L McWilliamsExecutive officerDec 2013
Michael J DotyExecutive officerDec 2013
Michael S. DotyExecutive officerJul 2013
Bruce Robertson, Ph.D.DirectorJan 2017
Jack NielsenDirectorJan 2017
John CreecyDirectorJan 2017
Matthew CrawfordDirectorJan 2017
R. Kent McGaughy, Jr.DirectorJan 2017
Richard MeeliaDirectorJan 2017
Rick AndersonDirectorJan 2017
Todd NewtonDirectorJan 2017
William McClellan, Jr.DirectorJan 2017
Bruce S RobertsonDirectorDec 2013
Dennis L McWilliamsDirectorDec 2013
Jack B NielsenDirectorDec 2013
John W CreecyDirectorDec 2013
Matthew S CrawfordDirectorDec 2013
R. Kent B McGaughy, Jr.DirectorDec 2013
Richard J MeeliaDirectorDec 2013
Rick J AndersonDirectorDec 2013
Bruce S. RobertsonDirectorJul 2013
Dennis McWilliamsDirectorJul 2013
Jack S. NielsenDirectorJul 2013
John S. CreecyDirectorJul 2013
Matthew S. CrawfordDirectorJul 2013
R. Kent S. McGaughy, Jr.DirectorJul 2013